文献
J-GLOBAL ID:201802261922101319
整理番号:18A0158518
TET2損失およびNRAS変異による協同的後成的リモデリング骨髄形質転換およびMEK阻害剤感受性を促進する【Powered by NICT】
Cooperative Epigenetic Remodeling by TET2 Loss and NRAS Mutation Drives Myeloid Transformation and MEK Inhibitor Sensitivity
著者 (35件):
Kunimoto Hiroyoshi
(Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA)
,
Kunimoto Hiroyoshi
(Center for Epigenetics Research, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA)
,
Kunimoto Hiroyoshi
(Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA)
,
Meydan Cem
(Institute for Computational Biomedicine and Department of Physiology and Biophysics, Weill Cornell Medical College, New York, NY 10065, USA)
,
Nazir Abbas
(Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA)
,
Nazir Abbas
(Center for Epigenetics Research, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA)
,
Nazir Abbas
(Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA)
,
Whitfield Justin
(Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA)
,
Whitfield Justin
(Center for Epigenetics Research, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA)
,
Whitfield Justin
(Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA)
,
Shank Kaitlyn
(Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA)
,
Shank Kaitlyn
(Center for Epigenetics Research, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA)
,
Shank Kaitlyn
(Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA)
,
Rapaport Franck
(Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA)
,
Rapaport Franck
(Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA)
,
Maher Rebecca
(University of Connecticut School of Medicine, Farmington, CT 06032, USA)
,
Pronier Elodie
(Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA)
,
Pronier Elodie
(Center for Epigenetics Research, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA)
,
Pronier Elodie
(Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA)
,
Meyer Sara C.
(Division of Hematology, University Hospital Basel, 4031 Basel, Switzerland)
,
Meyer Sara C.
(Department of Biomedicine, University Hospital Basel, 4031 Basel, Switzerland)
,
Garrett-Bakelman Francine E.
(Department of Medicine, Division of Hematology-Oncology, Weill Cornell Medical College, New York, NY 10065, USA)
,
Garrett-Bakelman Francine E.
(Department of Medicine, University of Virginia, Charlottesville, VA 22908, USA)
,
Garrett-Bakelman Francine E.
(Department of Biochemistry and Molecular Genetics, University of Virginia, Charlottesville, VA 22908, USA)
,
Tallman Martin
(Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA)
,
Melnick Ari
(Department of Medicine, Division of Hematology-Oncology, Weill Cornell Medical College, New York, NY 10065, USA)
,
Melnick Ari
(Department of Pharmacology, Weill Cornell Medical College, New York, NY 10065, USA)
,
Levine Ross L.
(Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA)
,
Levine Ross L.
(Center for Epigenetics Research, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA)
,
Levine Ross L.
(Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA)
,
Levine Ross L.
(Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA)
,
Shih Alan H.
(Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA)
,
Shih Alan H.
(Center for Epigenetics Research, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA)
,
Shih Alan H.
(Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA)
,
Shih Alan H.
(Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA)
資料名:
Cancer Cell
(Cancer Cell)
巻:
33
号:
1
ページ:
44-59.e8
発行年:
2018年
JST資料番号:
W1844A
ISSN:
1535-6108
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)